Related Experiment Videos
[Brain metastasis from breast cancer]
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|July 1, 1986
Summary
Brain metastasis in breast cancer patients receiving radiotherapy showed a 20% complete response rate. Better performance status and treatment response significantly improved survival outcomes for these advanced cancer patients.
Area of Science:
- Oncology
- Radiotherapy
- Medical Oncology
Context:
- Breast cancer brain metastasis presents a significant clinical challenge.
- Widespread metastasis and concurrent chemotherapy are common at diagnosis.
- Radiotherapy is a primary treatment modality for brain metastases.
Purpose:
- To evaluate the efficacy of whole-brain radiotherapy in breast cancer patients with brain metastasis.
- To identify prognostic factors influencing survival in this patient cohort.
Summary:
- Thirty-seven breast cancer patients with brain metastasis were analyzed.
- Radiotherapy (4,000 rads) yielded a 20% complete response and 17% partial response.
- Median survival was 6 months post-brain metastasis diagnosis; responders and those with better performance status survived longer.
Impact:
- Radiotherapy offers a survival benefit for select breast cancer patients with brain metastases.
- Performance status is a critical prognostic indicator.
- Further research into optimizing treatment strategies for brain metastases is warranted.